Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

472

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

472 results for “COVID 19”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov32/100

Methylprednisolone in Patients with Cognitive Deficits in Post-COVID-19 Syndrome (PCS)

ClinicalTrials.gov study NCT05986422. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Post-COVID 19 Patients Undergoing Surgery

ClinicalTrials.gov study NCT04922931. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Laser Therapy on Tension-type Cephalea and Orofacial Pain in Post-covid-19 Patients

ClinicalTrials.gov study NCT05430776. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
dryad32/100

Data from: HLA-G 14 bp variant is associated with exercise-induced oxygen desaturation in the post-COVID-19 condition

Open the record for dataset details and reuse information.

publicJun 2024View details →
dryad32/100

Temporal variability of microparticles under the Seattle Aquarium, WA: Documenting the global Covid‐19 pandemic

Open the record for dataset details and reuse information.

publicSep 2021View details →
zenodo28/100

Web Scrap of main informations on COVID 19 macro data per country

<p>We&#39;ve gathered a single point of the worldwide evolution of daily cases of population affected by COVID 19 crises.</p> <p>Information is web-scrapped&nbsp;twice a day on the below fields.</p> <p>&nbsp;</p> <p><strong>dateTime</strong> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;type&nbsp;STRING &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;Fecha de la captura del datos</p> <p><strong>country</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;type&nbsp;STRING &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;Pa&iacute;s al que hacen referencia los datos, salvo un crucero&quot;</p> <p><strong>total_cases</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;type&nbsp;INT &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;N&uacute;mero total de casos que se han contabilizado en el pa&iacute;s&quot;</p> <p><strong>new_cases</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total de casos incrementados desde la info anterior en el pa&iacute;s&quot;</p> <p><strong>total_deaths</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; type&nbsp;INT &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;N&uacute;mero total de fallidos en el pa&iacute;s &quot;</p> <p><strong>new_deathts</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total de fallecidos incrementados desde la info anterior en el pa&iacute;s&quot;</p> <p><strong>total_recovered &nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong>type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total dados de alta&nbsp;en el pa&iacute;s&quot;</p> <p><strong>active_cases &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong>type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;Casos que est&aacute;n recibiendo tratamiento&nbsp;en el pa&iacute;s&quot;</p> <p><strong>critical_cases &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;</strong>type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total de casos en la UCI en el pa&iacute;s&quot;</p> <p><strong>cases_per_million &nbsp; &nbsp; &nbsp;&nbsp;</strong>type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total de casos&nbsp;por mill&oacute;n de habitantes&nbsp;en el pa&iacute;s&quot;</p> <p><strong>deaths_per_million&nbsp;&nbsp; &nbsp;&nbsp;</strong>type&nbsp;INT &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &quot;N&uacute;mero total de fallecidos por mill&oacute;n de habitantes&nbsp;en el pa&iacute;s&quot;</p>

opencc-by-4.0Apr 2020View details →
zenodo28/100

Identification and validation of 174 COVID‑19 vaccine candidate epitopes reveals low performance of common epitope prediction tools

<p>Datasets used in &quot;Identification and validation of 174 COVID‑19 vaccine candidate epitopes reveals low performance of common epitope prediction tools&quot;</p> <p>sars-cov-2_predicted.csv</p> <p>SARS-CoV-2 peptides predicted to be binders to 11 HLA alleles by the NetMHC suite tools, these selected peptides have been measured in a stability assay revealing SARS-CoV-2 epitopes (assay results can be found at: https://www.immunitrack.com/free-coronavirus-report-for-download/).&nbsp;</p> <p>tools_predictions_binders.xlsx</p> <p>File containing all predictions for tools&nbsp;tested in the benchmark&nbsp;(note that not all tools use same measure). List of binders (epitopes) with IEDB links and T cell studies overlap.</p>

opencc-by-4.0Nov 2020View details →
zenodo28/100

Factores que inciden en la decisión de compra del consumidor post COVID 19 en los puntos de ventas Retailing

<p>Ponencia - IV Congreso Latinoamericano de Marketing Social</p>

opencc-by-4.0Oct 2022View details →
zenodo28/100

COVID – 19 BILAN KASALLANGAN BOLALARDA BUYRAK PATOLOGIYASI

Open the record for dataset details and reuse information.

opencc-by-4.0Apr 2024View details →
zenodo28/100

Mental Health Outcomes and Their Correlates in the Post-COVID-19 Era Among University Students and Staff in Indonesia

Open the record for dataset details and reuse information.

opencc-by-4.0Nov 2024View details →
zenodo28/100

COVID 19 Mental Health Survey May 2020-May 2021

<p>This data set assesses the mental health of four separate cohorts across mainly the UK and Germany each one at a different time point using an online survey.&nbsp;The COVID-19 exposure and COVID-19 related mental health survey was designed as an online survey using EvaSys (https://www.evasys.de, Electric Paper Evaluationssysteme GmbH, Luneburg, Germany), see Knolle et al. (2021, BMC psychology) or Daimer et al. (2021, Frontiers psychology)&nbsp; for a detailed description. The questionnaires were available in German and English. For participant recruitment we used a snowball sampling strategy to reach the general public in Germany and the UK. The &ldquo;Spring 2020 survey&rdquo; was collected from 27/04/2020 - 31/05/2020, approximately five weeks after the introduction of the nationwide lockdowns in the UK and Germany. Completion of this first survey took approximately 35 min. The three follow-up surveys took only about 15 minutes, as they did not include question on subjective change of psychological distress (&ldquo;Autumn 2020 survey&rdquo;: 10/09/2020 &ndash; 18/10/2020; &ldquo;Winter 2021 survey&rdquo;: 10/01/2021 &ndash; 07/02/2021; &ldquo;Spring 2021 survey&rdquo;: 01/05/2021 &ndash; 31/05/2021).</p>

opencc-by-4.0Dec 2021View details →
dryad28/100

Influence of COVID‑19 on the prognosis and medication compliance of glaucoma patients in the Nile Delta Region

<p><span>Purpose: To assess the influence of the COVID-19 pandemic on the medication adherence and follow-up of glaucoma patients in the Nile Delta Region.</span></p> <p><span><span>Patients and Methods:</span></span></p> <p><span><span>Study design: An observational cross-sectional study</span></span></p> <p><span><span>Study setting: Nile Delta Region, Egypt</span></span></p> <p><span>Patients' records (2019-2020; group A) and (2020-2021; group B) were assessed for missed follow-up visits, medication adherence, number of trabeulectomies performed, and number of uncontrolled patients. In addition, a telephone-based questionnaire involving randomly chosen 200 patients from B.G.U. was carried out to clarify the potential causes of poor patients' compliance.</span></p> <p><span>Results: There was a marked decline in the number of newly diagnosed patients and patients on regular follow-up with incidence rates 0.208 and 0.088 in group (A) and group (B), respectively. The number of compliant patients in the second year (group B) decreased, with an incidence rate difference of 0.312. The number of trabeculectomies declined in group (B) with an incidence rate in group (A) 0.131 compared to 0.081 in group (B). On the other hand, the number of uncontrolled glaucoma patients increased in group B with an incidence rate difference -0.231between the two groups. 21.5% of patients who participated in the questionnaire identified financial issues as the leading cause of non-compliance. Comorbidities (19.5%), lockdown and transportation difficulties were also highlighted. </span></p> <p><span>Conclusion: COVID-19 had greatly hampered glaucoma care in the Nile Delta region. As a result, we need to implement new technologies like telemedicine and improve patients' awareness of glaucoma care.</span></p>

opencc-zeroSep 2021View details →
zenodo28/100

Raw data- IDENTIFICATION PERFORMANCE DURING QUARANTINE BY COVID 19 PANDEMIC: INFLUENCE OF EMOTIONAL VARIABLES AND SLEEP QUALITY

<p>The raw data supporting the conclusions of this article</p>

opencc-by-4.0Oct 2021View details →
ClinicalTrials.gov28/100

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

ClinicalTrials.gov study NCT04603729. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome

ClinicalTrials.gov study NCT05534997. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals

ClinicalTrials.gov study NCT04409574. IPD Sharing: Not stated. Countries: 0. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

ClinicalTrials.gov study NCT05633407. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

ClinicalTrials.gov study NCT04798066. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Phase 2/3 Study to Evaluate FP-025 in Patients With Severe to Critical COVID 19

ClinicalTrials.gov study NCT04750278. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients

ClinicalTrials.gov study NCT05148858. IPD Sharing: UNDECIDED. Countries: 0. Publications: 10.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record